Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | McElrath: Innate to Adaptive Immunity |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2010-12-17 |
| Study Made Public: | 2014-11-10 |
Title
Immunogenicity and challenge following prime-boost immunization with MVA-SIV Env followed by Env protein plus Poly-ICLC adjuvant in NHP
Description
CAVD 260 is a non-human primate challenge study comparing prime/boost regimens of a Modified Vaccinia Ankara vaccine combined with envelope protein vaccine and the adjuvant, Poly-ICLC .
Sign in to see full information about this study and to download study data.
Products
SIVmac251 Rapamycin Placebo MVA Poly IC MVA-SIV-Env SIV-EnvIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.